BLISS GVS PHARMA Financial Statement Analysis
|
||
|
The Revenues of BLISS GVS PHARMA have increased by 2.48% YoY .
The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 6.03 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
BLISS GVS PHARMA Last 5 Annual Financial Results
[BOM: 506197|NSE : BLISSGVS]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr | ₹689 Cr |
| Expenses | ₹621 Cr | ₹634 Cr | ₹629 Cr | ₹471 Cr | ₹566 Cr |
| Operating Profit (Excl OI) | ₹149 Cr | ₹117 Cr | ₹118 Cr | ₹107 Cr | ₹123 Cr |
| Other Income | ₹30 Cr | ₹18 Cr | ₹31 Cr | ₹22 Cr | ₹39 Cr |
| Interest | ₹6.91 Cr | ₹10 Cr | ₹4.74 Cr | ₹7.24 Cr | ₹7.57 Cr |
| Depreciation | ₹26 Cr | ₹19 Cr | ₹17 Cr | ₹17 Cr | ₹13 Cr |
| Profit Before Tax | ₹117 Cr | ₹106 Cr | ₹54 Cr | ₹104 Cr | ₹129 Cr |
| Profit After Tax | ₹82 Cr | ₹77 Cr | ₹23 Cr | ₹74 Cr | ₹95 Cr |
| Consolidated Net Profit | ₹75 Cr | ₹71 Cr | ₹15 Cr | ₹68 Cr | ₹97 Cr |
| Earnings Per Share (Rs) | ₹7.21 | ₹6.80 | ₹1.45 | ₹6.64 | ₹9.43 |
| PAT Margin (%) | 10.59 | 10.21 | 3.09 | 12.82 | 13.82 |
| ROE(%) | 8.89 | 9.11 | 2.88 | 9.64 | 13.79 |
| ROCE(%) | 12.15 | 12.22 | 6.37 | 12.49 | 17.02 |
| Total Debt/Equity(x) | 0.09 | 0.11 | 0.13 | 0.15 | 0.16 |
Key Financials |
||
| Market Cap | : | ₹ 1,227.4 Cr |
| Revenue (TTM) | : | ₹ 809.9 Cr |
| Net Profit(TTM) | : | ₹ 68.7 Cr |
| EPS (TTM) | : | ₹ 6.5 |
| P/E (TTM) | : | 17.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BLISS GVS PHARMA | -7.7% | -6.9% | 0.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -6.7% | 2.6% | 5% |
| DIVIS LABORATORIES | -6.6% | -3.7% | 43.8% |
| CIPLA | -5.3% | -2.9% | -1.1% |
| TORRENT PHARMACEUTICALS | -3.8% | 1.8% | 25.8% |
| DR REDDYS LABORATORIES | -4.9% | -3.3% | -10.2% |
| MANKIND PHARMA | -4.7% | -0.1% | -0.1% |
| ZYDUS LIFESCIENCES | -6.3% | -6.3% | -14.6% |
| LUPIN | -8.3% | -5.3% | 24.1% |
BLISS GVS PHARMA Revenues
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 2.48 % |
| 5 Yr CAGR | 2.81 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹770 Cr | 2.48 | |
| Mar2023 | ₹752 Cr | 0.55 | |
| Mar2022 | ₹747 Cr | 29.50 | |
| Mar2021 | ₹577 Cr | -16.26 | |
| Mar2020 | ₹689 Cr | - | |
BLISS GVS PHARMA Operating Profit
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 26.98 % |
| 5 Yr CAGR | 4.84 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹149 Cr | 26.98 | |
| Mar2023 | ₹117 Cr | -0.86 | |
| Mar2022 | ₹118 Cr | 10.97 | |
| Mar2021 | ₹107 Cr | -13.52 | |
| Mar2020 | ₹123 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 23.89 % |
| 5 Yr CAGR | 1.97 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 19.34% | 23.89 | |
| Mar2023 | 15.61% | -1.39 | |
| Mar2022 | 15.83% | -14.34 | |
| Mar2021 | 18.48% | 3.30 | |
| Mar2020 | 17.89% | - | |
BLISS GVS PHARMA Profit After Tax
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 6.48 % |
| 5 Yr CAGR | -6.15 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹75 Cr | 6.48 | |
| Mar2023 | ₹71 Cr | 371.14 | |
| Mar2022 | ₹15 Cr | -78.04 | |
| Mar2021 | ₹68 Cr | -29.58 | |
| Mar2020 | ₹97 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 3.72 % |
| 5 Yr CAGR | -6.44 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 10.59 % | 3.72 | |
| Mar2023 | 10.21 % | 230.42 | |
| Mar2022 | 3.09 % | -75.90 | |
| Mar2021 | 12.82 % | -7.24 | |
| Mar2020 | 13.82 % | - | |
BLISS GVS PHARMA Earnings Per Share (EPS)
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | 6.03 % |
| 5 Yr CAGR | -6.49 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹7.21 | 6.03 | |
| Mar2023 | ₹6.80 | 368.97 | |
| Mar2022 | ₹1.45 | -78.16 | |
| Mar2021 | ₹6.64 | -29.59 | |
| Mar2020 | ₹9.43 | - | |
BLISS GVS PHARMA Return on Capital Employed (ROCE)
[BOM: 506197|NSE : BLISSGVS]
| Y-o-Y | -0.57 % |
| 5 Yr CAGR | -8.08 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 12.15% | -0.57 | |
| Mar2023 | 12.22% | 91.84 | |
| Mar2022 | 6.37% | -49.00 | |
| Mar2021 | 12.49% | -26.62 | |
| Mar2020 | 17.02% | - | |
BLISS GVS PHARMA Share Price vs Sensex
| Current Share Price | : | ₹116.5 |
| Current MarketCap | : | ₹ 1,227.4 Cr |
| Updated EOD on | : | Apr 09,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -7.7% |
-6.9% |
0.2% |
| SENSEX | -3.6% |
-0.7% |
-0.5% |
BLISS GVS PHARMA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | -2.9% | 1% | -1% |
| BSE HEALTHCARE | -3.8% | -0.4% | 11.4% |
| BSE MIDSMALLCAP | -5.4% | -1.5% | -2.8% |
| BSE SMALLCAP | -5.7% | -1.8% | -3% |
No NSE index found
You may also like the below Video Courses
FAQ about BLISS GVS PHARMA Financials
How the annual revenues of BLISS GVS PHARMA have changed ?
The Revenues of BLISS GVS PHARMA have increased by 2.48% YoY .
How the Earnings per Share (EPS) of BLISS GVS PHARMA have changed?
The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 6.03 % YoY .
Check out Intrinsic Value of Peers of BLISS GVS PHARMA
Compare Stock Analytics of Peers of BLISS GVS PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
